Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1988)
All Articles published online
|
Apr 7, 2007 (publication date) through May 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Weigand K, Stremmel W, Encke J. Treatment of hepatitis C virus infection. World J Gastroenterol 2007; 13(13): 1897-1905 [PMID: 17461488 DOI: 10.3748/wjg.v13.i13.1897] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i13/1897.htm |
| Number | Citing Articles |
| 1 |
Mohammad Amin Behzadi, Mazyar Ziyaeyan. Hepatitis C Virus Load in Seropositive Liver and Kidney Transplant Recipients by Quantitative Real-Time PCR Before and After Transplantation. Jundishapur Journal of Microbiology 2013; 6(8) doi: 10.5812/jjm.7365
|
| 2 |
S. Ramia, N. M. Melhem, K. Kreidieh. Hepatitis C virus infection in the Middle East and North Africa “MENA” region: injecting drug users (IDUs) is an under-investigated population. Infection 2012; 40(1): 1 doi: 10.1007/s15010-011-0236-z
|
| 3 |
Debasish Swain, Amrej Singh Yadav, Chandrasekhar Sasapu, Venkatakrishna Akula, Gananadhamu Samanthula. UPLC Separation of forced degradation and process related impurities of Velpatasvir and structure elucidation by online LC-Quadrupole-Time of flight-Tandem mass Spectrometry. Microchemical Journal 2020; 155: 104657 doi: 10.1016/j.microc.2020.104657
|
| 4 |
Toshana L. Foster, Philip R. Tedbury, Arwen R. Pearson, Mark Harris. A comparative analysis of the fluorescence properties of the wild-type and active site mutants of the hepatitis C virus autoprotease NS2-3. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2010; 1804(1): 212 doi: 10.1016/j.bbapap.2009.10.006
|
| 5 |
Philip Tedbury, Mark Harris. Viral Proteases and Antiviral Protease Inhibitor Therapy. 2009; : 47 doi: 10.1007/978-90-481-2348-3_3
|
| 6 |
Céline Giordano, Curtis Cooper. The influence of race and language on chronic hepatitis C virus infection management. European Journal of Gastroenterology & Hepatology 2009; 21(2): 131 doi: 10.1097/MEG.0b013e32830b387b
|
| 7 |
Nabiha Faisal, Khalid Mumtaz, Max Marquez, Eberhard L. Renner, Leslie B. Lilly. High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation. Hepatology International 2015; 9(1): 76 doi: 10.1007/s12072-014-9589-6
|
| 8 |
Shigeaki Ishii, Margaret James Koziel. Immune responses during acute and chronic infection with hepatitis C virus. Clinical Immunology 2008; 128(2): 133 doi: 10.1016/j.clim.2008.03.525
|
| 9 |
Dennis Revie, Michael O Alberti, John G Prichard, Ann S Kelley, S Zaki Salahuddin. Analysis of the 5'UTR of HCV genotype 3 grown in vitro in human B cells, T cells, and macrophages. Virology Journal 2010; 7(1) doi: 10.1186/1743-422X-7-155
|
| 10 |
Yeon-Joo Kim, Young-Il Kim, Young-A Song, Nam-Cheol Jin, Sung-Ryoun Lim, Dae-Yeul Ryang, Kyoung-Myeun Chung, Seon-Young Park, Chang-Hwan Park, Hyun-Soo Kim, Sung-Kyu Choi, Jong-Sun Rew. The Effectiveness of Combination Therapy with Peginterferon α-2a and Ribavirin in Chronic Hepatitis C. Chonnam Medical Journal 2008; 44(2): 72 doi: 10.4068/cmj.2008.44.2.72
|
| 11 |
Toshana L. Foster, Tamara Belyaeva, Nicola J. Stonehouse, Arwen R. Pearson, Mark Harris. All Three Domains of the Hepatitis C Virus Nonstructural NS5A Protein Contribute to RNA Binding. Journal of Virology 2010; 84(18): 9267 doi: 10.1128/JVI.00616-10
|
| 12 |
Cristiane da Silva Melo, Bruno Gonçalves Pereira, Armando Silva-Cunha, Sílvia Ligório Fialho. Poly-ε-caprolactone microspheres containing interferon alpha as alternative formulations for the treatment of chronic hepatitis C. Brazilian Journal of Pharmaceutical Sciences 2012; 48(1): 51 doi: 10.1590/S1984-82502012000100006
|
| 13 |
Freke Zuure, Susan Hahné, Thijs van de Laar, Maria Prins, Jim van Steenbergen. Modern Infectious Disease Epidemiology. Statistics for Biology and Health 2009; : 333 doi: 10.1007/978-0-387-93835-6_19
|
| 14 |
Jorge Méndez-Navarro, Ruby A. Chirino, Kathleen E. Corey, Emmanuel C. Gorospe, Hui Zheng, Segundo Morán, Raymond T. Chung, Margarita Dehesa-Violante. A Randomized Controlled Trial of Double Versus Triple Therapy with Amantadine for Genotype 1 Chronic Hepatitis C in Latino Patients. Digestive Diseases and Sciences 2010; 55(9): 2629 doi: 10.1007/s10620-009-1062-3
|
| 15 |
Liz Alvarez‐Lajonchere, Yalena Amador‐Cañizares, Roberto Frías, Yoamel Milian, Alexis Musacchio, Ivis Guerra, Nelson Acosta‐Rivero, Gillian Martínez, Jorge Castro, Pedro Puentes, Karelia Cosme, Santiago Dueñas‐Carrera. Immunization with a recombinant fowlpox virus expressing a hepatitis C virus core–E1 polyprotein variant, protects mice and African green monkeys (Chlorocebus aethiops sabaeus) against challenge with a surrogate vaccinia virus. Biotechnology and Applied Biochemistry 2008; 51(2): 97 doi: 10.1042/BA20070182
|
| 16 |
K. Kumthip, C. Pantip, P. Chusri, S. Thongsawat, A. O’Brien, K. E. Nelson, N. Maneekarn. Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy. Journal of Viral Hepatitis 2011; 18(4) doi: 10.1111/j.1365-2893.2010.01379.x
|
| 17 |
Ramin Yaghobi, Mohammad Javad Kazemi, Bita Geramizadeh, Seyed Ali Malek Hosseini, Javad Moayedi. Significance of Occult Hepatitis C Virus Infection in Liver Transplant Patients With Cryptogenic Cirrhosis. Experimental and Clinical Transplantation 2020; 18(2): 206 doi: 10.6002/ect.2017.0332
|